The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock (Q35101483)

6 August 2017

1 reference

title

The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock (English)

1 reference

6 August 2017

0 references

1 reference

David R Williamson

1

1 reference

6 August 2017

Marc Lapointe

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

23

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

514-525

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Has the mortality of septic shock changed with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Steroid controversy in sepsis and septic shock: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Sepsis research: we must change course

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effect of cortisone on acute streptococcal infections and poststreptococcal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Hydrocortisone and the reduction of vasopressors in septic shock: therapy or only chart cosmetics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Stress doses of glucocorticoids in catecholamine dependency: a new therapy for a new syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroids in septic shock: resurrection of the last rites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

From mega to more reasonable doses of corticosteroids: a decade to recreate hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

New rationale for glucocorticoid treatment in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Are endogenous glucocorticoid levels adequate in septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Steroid replacement in sepsis: an unexplored side of a multifaceted drug class

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Hypothalamic-pituitary-adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroid Therapy in Severe Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroid supplementation for adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenal insufficiency during the late stage of polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Cortisol response to corticotropin and survival in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Iontophoretic delivery of calcium for experimental hydrofluoric acid burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Assessing the hypothalamo-pituitary-adrenocortical axis using physiological doses of adrenocorticotropic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The Effect of Interleukin-6 on Pituitary Hormone Release in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Interleukin-6 and the Interleukin-6 Receptor in the Human Adrenal Gland: Expression and Effects on Steroidogenesis1

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroids for septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Increased nuclear factor kappa B activation in critically ill patients who die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Role of NFkappaB in the mortality of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The IKK/NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Hydrocortisone-induced inhibition of reactive oxygen species by polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The pathogenesis of vasodilatory shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Depletion of neurohypophyseal content of vasopressin in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Treating patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Medical responsibility in orthetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Steroids in the treatment of clinical septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Contribution of cortisol deficiency to septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenocortical function during septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The effect of methylprednisolone on myocardial beta-adrenergic receptors and cardiovascular function in shock patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenal functions in patients with sepsis*

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

21 January 2018

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

A comparison of the adrenocortical response during septic shock and after complete recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Relative eosinophilia and functional adrenal insufficiency in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Sepsis-induced adrenal deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Mechanisms of Adrenocortical Depression During Escherichia coli Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effects of septic shock plasma on adrenocortical cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Effectiveness of modified steroid-antibiotic therapies for lethal sepsis in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

Survival of primates in LD100 septic shock following steroid/antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

The cardiopulmonary response to massive doses of steroids in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592/PHCO.23.4.514.32123

10.1592/PHCO.23.4.514.32123

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference